What is Adaptive Biotechnologies's revenue?

Adaptive Biotechnologies (ADPT) generated $295.4M in revenue over the trailing twelve months, up 55.9% year over year.

Is Adaptive Biotechnologies profitable?

Adaptive Biotechnologies is not currently profitable: it reported a net loss of $49.7M over the trailing twelve months, a -16.8% net margin.

What are Adaptive Biotechnologies's profit margins?

Gross margin is 75.3% and operating margin is -15.8%, with a -16.8% net margin.

What is Adaptive Biotechnologies's earnings per share?

Adaptive Biotechnologies's diluted EPS over the trailing twelve months is $-0.33.

Where does Adaptive Biotechnologies's income statement data come from?

Every line is extracted from Adaptive Biotechnologies's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Adaptive Biotechnologies ADPT Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Total revenue	$276.98M+54.8%	$178.96M+5.1%	$170.28M-8.1%	$185.31M+20.1%
Total cost of revenue	$71.36M-1.0%	$72.08M-4.6%	$75.55M+30.5%	$57.91M+17.5%
Gross profit	$205.62M+92.4%	$106.88M+12.8%	$94.72M-25.6%	$127.4M+21.3%
Gross margin	74.2%+14.5pp	59.7%+4.1pp	55.6%-13.1pp	68.7%+0.7pp
Research and development	$93.77M-8.9%	$102.95M-15.7%	$122.12M-13.9%	$141.76M-0.4%
Selling and marketing	$94.57M+11.6%	$84.76M-4.3%	$88.58M-7.3%	$95.6M+0.1%
General and administrative	$72.7M-0.1%	$72.81M-13.3%	$83.93M-5.2%	$88.53M+18.8%
Depreciation and amortization	$1.7M-0.2%	$1.7M+0.2%	$1.7M0.0%	$1.7M0.0%
Total costs & expenses	$334.1M-2.2%	$341.51M-14.0%	$397.31M+3.1%	$385.49M+6.1%
Operating income	-$57.12M+64.9%	-$162.55M+28.4%	-$227.04M-13.4%	-$200.19M+4.2%
Operating margin	-20.6%+70.2pp	-90.8%+42.5pp	-133.3%-25.3pp	-108%+27.4pp
Interest income	$9.44M-35.0%	$14.53M-6.4%	$15.53M+283%	$4.06M+143%
Net income	-$59.5M+62.7%	-$159.49M+29.2%	-$225.25M-12.5%	-$200.19M+3.4%
Net margin	-21.5%+67.6pp	-89.1%+43.2pp	-132.3%-24.3pp	-108%+26.3pp
Diluted earnings per share	-$0.40+63.0%	-$1.08+30.8%	-$1.56-10.6%	-$1.41+4.7%
Basic earnings per share	-$0.40+63.0%	-$1.08+30.8%	-$1.56-10.6%	-$1.41+4.7%
Weighted-average shares, diluted	616.2M+4.8%	587.8M+1.9%	577M+1.3%	569.5M+1.6%
Weighted-average shares, basic	605.4M+3.0%	587.8M+1.9%	577M+1.3%	569.5M—
Amortization of capitalized software and acquired intangible assets	$1.7M-0.2%	$1.7M+0.2%	$1.7M0.0%	$1.7M0.0%
Interest income and other, net	$9.44M-35.0%	$14.53M-6.4%	$15.53M+283%	$4.06M+143%
Revenue From Contract With Customer Excluding Assessed Tax	$276.98M+54.8%	$178.96M+5.1%	$170.28M-8.1%	$185.31M+20.1%
EBIT	-$57.12M+64.9%	-$162.55M+28.4%	-$227.04M-13.4%	-$200.19M+4.2%
EBITDA	-$39.29M+72.6%	-$143.29M+30.0%	-$204.8M-14.2%	-$179.27M+8.1%
EBITDA	-$39.29M+72.6%	-$143.29M+30.0%	-$204.8M-14.2%	-$179.27M+8.1%
EBITDA margin	-14.2%+65.9pp	-80.1%+40.2pp	-120.3%-23.5pp	-96.7%+29.6pp
EBIT	-$57.12M+64.9%	-$162.55M+28.4%	-$227.04M-13.4%	-$200.19M+4.2%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Adaptive Biotechnologies.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Adaptive Biotechnologies's revenue?: Adaptive Biotechnologies (ADPT) generated $295.4M in revenue over the trailing twelve months, up 55.9% year over year.
Is Adaptive Biotechnologies profitable?: Adaptive Biotechnologies is not currently profitable: it reported a net loss of $49.7M over the trailing twelve months, a -16.8% net margin.
What are Adaptive Biotechnologies's profit margins?: Gross margin is 75.3% and operating margin is -15.8%, with a -16.8% net margin.
What is Adaptive Biotechnologies's earnings per share?: Adaptive Biotechnologies's diluted EPS over the trailing twelve months is $-0.33.
Where does Adaptive Biotechnologies's income statement data come from?: Every line is extracted from Adaptive Biotechnologies's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.